PL3591402T3 - Urządzenie i sposób wykrywania przeciwciał - Google Patents

Urządzenie i sposób wykrywania przeciwciał

Info

Publication number
PL3591402T3
PL3591402T3 PL19179434T PL19179434T PL3591402T3 PL 3591402 T3 PL3591402 T3 PL 3591402T3 PL 19179434 T PL19179434 T PL 19179434T PL 19179434 T PL19179434 T PL 19179434T PL 3591402 T3 PL3591402 T3 PL 3591402T3
Authority
PL
Poland
Prior art keywords
antibody detection
antibody
detection
Prior art date
Application number
PL19179434T
Other languages
English (en)
Inventor
Katja Morgenroth
Vanessa Viertel
Ulf Steller
Stefan Gerlach
Christian Marzahl
Jörn Voigt
Winfried STÖCKER
Original Assignee
Euroimmun Medizinische Labordiagnostika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euroimmun Medizinische Labordiagnostika Ag filed Critical Euroimmun Medizinische Labordiagnostika Ag
Publication of PL3591402T3 publication Critical patent/PL3591402T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64—Fluorescence; Phosphorescence
    • G01N21/6486—Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/76—Chemiluminescence; Bioluminescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2201/00—Features of devices classified in G01N21/00
    • G01N2201/10—Scanning

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plasma & Fusion (AREA)
  • Optics & Photonics (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
PL19179434T 2018-07-06 2019-06-11 Urządzenie i sposób wykrywania przeciwciał PL3591402T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18182267.7A EP3591406A1 (de) 2018-07-06 2018-07-06 Vorrichtung und verfahren zur antikörperdetektion
EP19179434.6A EP3591402B1 (de) 2018-07-06 2019-06-11 Vorrichtung und verfahren zur antikörperdetektion

Publications (1)

Publication Number Publication Date
PL3591402T3 true PL3591402T3 (pl) 2021-06-14

Family

ID=62904287

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19179434T PL3591402T3 (pl) 2018-07-06 2019-06-11 Urządzenie i sposób wykrywania przeciwciał

Country Status (5)

Country Link
US (1) US20200011862A1 (pl)
EP (2) EP3591406A1 (pl)
CN (1) CN110687082A (pl)
ES (1) ES2850126T3 (pl)
PL (1) PL3591402T3 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3767587A1 (de) 2019-07-19 2021-01-20 Euroimmun Medizinische Labordiagnostika AG Detektion von präsenzen unterschiedlicher antinukleärer antikörper-fluoreszenzmustertypen und vorrichtung hierfür

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2318779C (en) * 1998-01-22 2009-08-25 Luminex Corporation Microparticles with multiple fluorescent signals
JP2002542487A (ja) 1999-04-15 2002-12-10 ザ、ボード、オブ、トラスティーズ、オブ、ザ、リーランド、スタンフォード、ジュニア、ユニバーシティ ポリペプチドのマイクロアレイ
CN1356554A (zh) * 2001-11-23 2002-07-03 上海晶泰生物技术有限公司 肝病诊断蛋白质芯片
US7960184B2 (en) 2002-09-20 2011-06-14 George Mason Intellectual Properties, Inc. Methods and devices for active bioassay
TWI323745B (en) 2003-06-11 2010-04-21 Neupro Technology Co Ltd Method of microwave-assisted protein array fabrication
JP4458327B2 (ja) * 2003-08-28 2010-04-28 キヤノン株式会社 標的物質の定量方法および該方法に用いるプローブ担体
US20050124017A1 (en) 2003-12-05 2005-06-09 Stewart Lebrun Quantitative alkaline-phosphatase precipitation reagent and methods for visualization of protein microarrays
FR2864550B1 (fr) * 2003-12-29 2006-02-24 Commissariat Energie Atomique Puce d'analyse avec gamme etalon, trousses et procedes d'analyse.
GB0409771D0 (en) * 2004-04-30 2004-06-09 Mabtech Ab Assay
DE102006027517A1 (de) * 2006-06-09 2007-12-13 Euroimmun Medizinische Labordiagnostika Ag Verfahren zur Erzeugung perfekter Macro- und Microarrays durch Kombinieren vorselektierter beschichteter Festphasen-Fragmente
JP2011503586A (ja) * 2007-11-13 2011-01-27 メディパン・ゲーエムベーハー 間接免疫蛍光測定法による最終抗体価の測定方法およびその評価方法
ES2425540T3 (es) 2010-02-22 2013-10-16 Medipan Gmbh Procedimiento y dispositivo para la detección simultánea de anticuerpos unidos a sustratos sintéticos y celulares y/o tisulares
CN202057653U (zh) * 2010-06-21 2011-11-30 才新 Hla抗体特异性检测双色荧光编码微颗粒试剂盒
WO2012037369A1 (en) 2010-09-15 2012-03-22 Mbio Diagnostics, Inc. System and method for detecting multiple molecules in one assay
EP2628006A4 (en) 2010-10-17 2014-05-21 Yeda Res & Dev MARKER FOR PRIMARY TRANSPLANT DYSFUNCTIONS
JP2014501932A (ja) 2011-01-05 2014-01-23 ゼウス サイエンティフィック、インク． 診断方法
CN107469878B (zh) 2011-04-13 2021-01-15 阿科尼生物系统公司 基于微阵列的样检系统
WO2014070235A1 (en) * 2012-10-29 2014-05-08 Mbio Diagnostics, Inc. Biological particle identification system, cartridge and associated methods
WO2014160175A1 (en) * 2013-03-14 2014-10-02 The Board Of Trustees Of The Leland Stanford Junior University Plasmonic substrate for multiplex assessment of type 1 diabetes
CN104634962A (zh) * 2013-11-11 2015-05-20 中国计量科学研究院 一种抗核抗体定量检测试剂盒和使用方法
FR3019901B1 (fr) * 2014-04-09 2020-10-30 Bio Rad Innovations Marqueur de controle pour la mise en oeuvre de procedes d'analyse sur spots
WO2017025954A1 (en) 2015-08-09 2017-02-16 Immunarray Ltd Methods for determining the risk of a systemic lupus erythematosus (sle) patient to develop neuropsychiatric syndromes

Also Published As

Publication number Publication date
ES2850126T3 (es) 2021-08-25
US20200011862A1 (en) 2020-01-09
EP3591406A1 (de) 2020-01-08
CN110687082A (zh) 2020-01-14
EP3591402A1 (de) 2020-01-08
EP3591402B1 (de) 2020-11-18

Similar Documents

Publication Publication Date Title
GB2573616B (en) Transporting device position determining apparatus and method
GB201818076D0 (en) Improved device and method for modualating information
IL281302A (en) Method and device for classifying objects
ZA201900665B (en) Method and device for signal detection
IL271806A (en) Method and device for detecting cutting tools
EP3401672A4 (en) WEAK SITE DETECTION DEVICE AND WEAK SITE DETECTION METHOD
SG11202100089PA (en) Detection device and detection method
GB2573752B (en) Sensor device and method
EP3818423A4 (en) MOBILE DEVICE AND ITS OBJECT DETECTION METHOD
GB2578226B (en) Sensor device and method
GB202005064D0 (en) Device and method for detecting objects
EP3805735A4 (en) FAULT DETECTION METHOD AND DEVICE
EP3791665A4 (en) METHOD AND DEVICE FOR MEASUREMENT RESTRICTIONS
SG11202013089PA (en) Method for configuring pdcch detection and related device
EP3845889A4 (en) INSPECTION DEVICE AND INSPECTION PROCEDURE
EP3816829A4 (en) DETECTION DEVICE AND DETECTION METHOD
PL3603389T3 (pl) Rolnicze urządzenie wykrywające i sposób wykrywania obiektów rolniczych
LT3752836T (lt) Sudėtinių dalių aptikimo būdai ir aparatas
GB202206029D0 (en) Analyte detection method and device
EP4083906A4 (en) OBJECT SEARCH APPARATUS AND OBJECT SEARCH METHOD
GB201807414D0 (en) Testing device and method
PL3591402T3 (pl) Urządzenie i sposób wykrywania przeciwciał
EP3644046A4 (en) SAMPLING DEVICE AND SAMPLING METHOD
IL263980A (en) A method for detecting radars and a corresponding device
EP3732926A4 (en) METHOD AND DEVICE FOR NPRACH DETECTION